ConductScience.org, home

Trial · NCT07882459

Individualized Management of Plaque-Related Gingival Inflammation in Routine Dental Practice

NCT07882459, Not applicable, Not yet recruiting, Curaden AG

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Individualized Management of Plaque-Related Gingival Inflammation in Routine Dental Practice. Trials, record NCT07882459. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07882459

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Individualized Management of Plaque-Related Gingival Inflammation in Routine Dental Practice
NCT number
NCT07882459
Status
Not yet recruiting
Phases
Not applicable
Enrollment
100 participants, estimated
Lead sponsor
Curaden AG
Conditions
Plaque-Induced Gingivitis
Interventions
Structured Preventive Care Workflow (iMGi)
First posted
2026-10-20
Last updated
2026-10-20

Source ClinicalTrials.gov

Registered outcomes16

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryParticipant Completion of the iMGi WorkflowFrom baseline (T0) to final follow-up (T5), approximately 10 months
Proportion of enrolled participants who complete the full structured preventive care workflow, including the scheduled visits from baseline (T0) through the final follow-up (T5). Calculated as the number of participants completing the workflow divided by the total number of enrolled participants, expressed as a percentage.
PrimaryAdherence to Predefined iMGi Workflow StepsAcross study visits from T0 through T5, approximately 10 months
Proportion of study visits during which all predefined steps of the structured iMGi preventive care workflow are performed as planned. Calculated as the number of visits with complete adherence to the predefined workflow steps divided by the total number of evaluable visits, expressed as a percentage.
SecondaryChange in Bleeding on Interdental Brushing (BOB) IndexBaseline (T0) and final follow-up (T5), approximately 10 months
Change in interdental gingival bleeding between baseline (T0) and final follow-up (T5), assessed using the Bleeding on Interdental Brushing (BOB) Index. Results are expressed as the percentage of evaluated interdental sites presenting bleeding following interdental brushing.
SecondaryLongitudinal Changes in BOB ScoreBaseline (T0) through final follow-up (T5), approximately 10 monthsBOB Scores, expressed as percentages, measured across study visits to describe the trajectory of interdental gingival bleeding during implementation of the structured preventive care workflow.
SecondaryChange in Full Mouth Bleeding Score (FMBS)Baseline (T0) and final follow-up (T5), approximately 10 monthsChange in the percentage of periodontal sites presenting bleeding on probing, assessed using the Full Mouth Bleeding Score (FMBS).
SecondaryChange in Full Mouth Plaque Score (FMPS)Baseline (T0) and final follow-up (T5), approximately 10 monthsChange in the percentage of tooth surfaces presenting plaque, assessed using the Full Mouth Plaque Score (FMPS).
SecondaryChange in Periodontal Pocket Depth (PPD)Baseline (T0) and final follow-up (T5), approximately 10 monthsChange in periodontal probing depth, measured in millimetres using periodontal charting.
SecondaryChange in Gingival Margin LevelBaseline (T0) and final follow-up (T5), approximately 10 monthsChange in gingival margin position, measured in millimetres relative to the cementoenamel junction.
SecondaryChange in Oral Health Motivation Scale (OHMS) ScoresBaseline (T0) and final follow-up (T5), approximately 10 monthsChange in questionnaire scores assessing oral health motivation and related behaviours.
SecondaryChange in Health Belief Model (HBM) Questionnaire ScoresBaseline (T0) and final follow-up (T5), approximately 10 monthsChange in questionnaire scores assessing health beliefs and perceptions related to oral health and preventive behaviours.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07882459

GET https://conductscience.org/api/trials/v1/NCT07882459/registered